Oncolytics Biotech Inc ONCY

Primary Symbol: T.ONC

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > National Bank Financial dropped the price $0.06 in aftermark

<< Previous

Bullboard Posts

Next >>

Comment by Lesalpes29on Sep 17, 2022 6:52am

168 Views

Post# 34968698

RE:National Bank Financial dropped the price $0.06 in aftermark

Noteable wrote: National Bank Financial dropped the price $0.06 on the TSX in after-market trading. From Cdn $1.78 to Cdn 1.72 - Shady trading going on.

The same happened on the NASDAQ with the price being hit in the after-market from US$ 1.35 to US$1.31. Aftermarket shady trading dropping the close has been happenig on the NASDAQ for some time.

Doing this cheap trading Day after day. Let them play when they can! I'm Here for the end of the game and really think it will be a buyout. Have a good week-end everyone

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing